Twenty-one patients with disseminated malignant melanoma were treated with a combination of carboplatin and cytosine arabinoside. Two complete and three partial remissions occurred. No complete cross-resistance was found with a regimen containing 5-(dimethyltriazeno)imidazole-4-carboxamide (DTIC) in two patients. It is suggested that this regimen might be studied further as a second-line treatment for patients who fail on DTIC-containing treatment.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/BF01612907 | DOI Listing |
Publication Analysis
Top Keywords
carboplatin cytosine
8
cytosine arabinoside
8
patients disseminated
8
disseminated malignant
8
malignant melanoma
8
phase study
4
study carboplatin
4
patients
4
arabinoside patients
4
melanoma twenty-one
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!